Trans/cis isomerization of [RuCl2{H2C=C(CH2PPh2)2)}(diamine)] complexes: synthesis, spectral, crystal structure and DFT calculations and catalytic activity in the hydrogenation of α,β-unsaturated ketones

Probing the effect of heterocycle-bonding in PNX-type ruthenium pre-catalysts for reactions involving H2

This study describes a series of ruthenium complexes with PNX-type ligands (X = heterocyclic donor group), and their catalytic activities in hydrogenation and dehydrogenation reactions are compared.

Synthesis, spectral and catalytic dehydrogenation studies of ruthenium complexes containing NO bidentate ligands

The synthesis and characterization of ruthenium mononuclear complexes containing NO bidentate ligands are reported. The complexes cis-[Ru(II)(bpy)2L](PF6)n (1a-c), [Ru(III)Cl(L)2(H2O)] (2a-b) and [Ru(III)Cl2(L)2]Cl (2c) were prepared by the reaction of cis-[Ru(II)Cl2(bpy)2]·2H2O (bpy=2,2'-bipyridine) and/or RuCl3·nH2O with the Ligands: 2-aminophenol (2-aph), 8-hydroxyquinoline (8-hq) and 4-aminoantipyrine (4-apy). These complexes were characterized by elemental analysis, spectroscopic (IR, UV-Vis, (1)H NMR, ESR) and magnetic susceptibility measurements. The ligand field parameters, Δo (splitting parameter), B (Racah parameter of interelectronic repulsion), and β (nephelauxetic ratio) were calculated. The redox properties were also investigated electrochemically by cyclic voltammetry. The complexes cis-[Ru(II)(bpy)2(8-hq)](PF6)2 (1b) and [Ru(III)Cl(8-hq)2(H2O)] (2b) have been investigated in conjunction with N-methylmorpholine-N-oxide (NMO) as co-oxidant for the catalytic dehydrogenation of benzyl amine, p-methyl benzylamine and p-nitrobenzylamine to their respective nitriles.

Design, synthesis, characterization of novel ruthenium(II) catalysts: highly efficient and selective hydrogenation of cinnamaldehyde to (E)-3-phenylprop-2-en-1-ol

In this contribution, two novel supported and non-supported ruthenium(II) complexes of type [RuCl2(dppme)(NN)] where [dppme is H2C=C(CH2PPh2)2 and NN is N1-(3-(trimethoxysilyl)propyl)ethane-1,2-diamine] were prepared. The NN co-ligand caused release of one of the dppme ligands from [RuCl2(dppme)2] precursor to yield complex 1. The process of substitution of dppme by NN was monitored by 31P{1H}-NMR. Taking advantage of the presence of trimethoxysilane group in the backbone of complex 1, polysiloxane xerogel counterpart, X1, was prepared via sol-gel immobilization using tetraethoxysilane as cross-linker. Both complexes 1 and X1 have been characterized via elemental analysis, CV and a number of spectroscopic techniques including FT-IR, 1H-, 13C-, and 31P-NMR, and mass spectrometry. Importantly, carbonyl selective hydrogenation was successfully accomplished under mild conditions using complex 1 as a homogenous catalyst and X1 as a heterogeneous catalyst, respectively.

Heterotrimetallic Ru(II)/Pd(II)/Ru(II) complexes: synthesis, crystalstructure, spectral characterization, DFT calculation and antimicrobial study

New ruthenium(II) mononuclear complexes of the type [RuCl2(PPh3)2(η(2)-triamine)] (2) [RuCl(PPh3)2(η(3)-triamine)]Cl (5) (triemine=N(1)-(2-aminoethyl)-1,2-ethanediamine) have been synthesized by reacting [RuCl2(PPh3)3] (1) with one mole equivalent of N(1)-(2-aminoethyl)-1,2-ethanediamine in dichloromethane. Reaction of (2) with half-equivalent of (PhCN)2PdCl2 or Pd(OAc)2 in dichloromethane as a solvent afforded two novel heterotrimetallic Ru(II)-Pd(II)-Ru(II) complexes, [Ru(II)Cl2(PPh3)2(triamine)]2[Pd(II)X2](X=Cl, OAc) (3 and 4), bearing bioactive ligand. The progress of the undertaken reactions was monitored by (31)P{1H} NMR and FTIR. Crystal structure of complex 2 was confirmed by X-ray diffraction. The absorption spectrum of 2 in dichloromethane was modeled by time-dependent density functional theory (TD-DFT). The in vitro antimicrobial studies of complex 2-5 against an array of microorganisms (bacteria and fungi) were conducted. Complexes 3 and 4 exhibit high dual antibacterial and antifungal activity inhibiting microorganisms possibly via hydrolytic pathway which further evidenced by electrochemical analyses. The complexes 3 and 4 show a high inhibitory activity at 200 μg/ml concentration, suggesting that complexes 3 and 4 are two efficient catalytic inhibitor of microorganisms and further, they should be tested against cancer strains.